Novo Nordisk Reports 16% YOY Growth in Q3, Raises Full-Year Guidance
Denmark-based biopharma Novo Nordisk A/S (NYSE: NVO) has released its Q3 2022 earnings report. The...
Novo Nordisk Partners with Shanghai Pharma for Smart Logistics at CIIE
Novo Nordisk (NYSE: NVO) has announced a strategic partnership with China’s Shanghai Pharmaceuticals (HKG: 2607,...
SIMR Biotechnology Raises RMB 150M in Series C1 Financing Round
China’s Shanghai SIMR Biotechnology Co., Ltd has reportedly raised RMB 150 million (USD 20.7 million)...
PingAn Good Doctor Partners with Roche and OrigiMed at CIIE
The 5th China International Import Expo (CIIE) saw China-based Ping An Healthcare and Technology Co.,...
Organon Partners with Alibaba Health to Enhance Chronic Disease Management
Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...
Qilu Pharma’s QL1706 Shows Promise in Phase II Cervical Cancer Study
China-based Qilu Pharmaceutical has published the latest results from a Phase II clinical study for...
Organon Sponsors Retail Pharmacy Health Center at CIIE
The 5th China International Import Expo (CIIE) saw Organon & Co. (NYSE: OGN), a firm...
Sanofi Partners with China Resources Sanjiu at CIIE for Consumer Healthcare
The 5th China International Import Expo (CIIE) saw Sanofi’s consumer healthcare unit announce a partnership...
Sumitomo Dainippon Partners with Profex to Promote Antipsychotics in China
Japan-based Sumitomo Dainippon Pharma Co., Ltd has announced a partnership with Profex, a trade company...
Eli Lilly Partners with AmoyDx and Burning Rock for Retevmo Companion Diagnostics
The 5th China International Import Expo (CIIE) saw US-based Eli Lilly (NYSE: LLY) announce a...
BioNTech’s Comirnaty Gets Limited Authorization in China Amid Scholz Visit
Germany-based mRNA specialist BioNTech (NASDAQ: BNTX) reportedly benefited from German Chancellor Olaf Scholz’s visit to...
Organon’s Q3 Results Show Women’s Health Segment Outperforms Amid Global Revenue Decline
US-based Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health...
Organon Signs MOU with China’s National Health Commission at CIIE
Organon & Co. (NYSE: OGN), a firm with a strong focus on women’s health that...
Ascletis Pharma Presents Phase I Study Results for ASC43F at AASLD
China-based Ascletis Pharma Inc. (HKG: 1672) made a poster presentation detailing the abstract of a...
Ji Xing Pharmaceuticals’ Omecamtiv Mecarbil Accepted for Review by CDE
Shanghai-based Ji Xing Pharmaceuticals, backed by RTW Investments, announced that a market filing for its...
Sophway Raises ‘Tens of Millions’ in Angel Round for Endoscope Development
Sophway Technology, a full HD endoscope system developer based in Shenzhen, has reportedly raised “tens...
CIIE: MET HER2 Precision Diagnosis Alliance Formed to Advance Lung Cancer Treatment
The 5th China International Import Expo (CIIE) witnessed the establishment of the MET HER2 precision...
CIIE: Bo’ao Lecheng Zone Announces Partnerships with Multinationals
The 5th China International Import Expo (CIIE) saw the Bo’ao Lecheng Medical Tourism Pilot Zone...
Cytiva Announces RMB 60M Investment for China Science Innovation Center at CIIE
Cytiva—formerly GE Healthcare Life Sciences and now the life science platform of Danaher Corporation—announced at...
Innovent Biologics’ Tafolecimab Shows Strong LDL-C Reduction in Phase III Study
China-based Innovent Biologics, Inc. (HKG: 1801) announced the results of the Phase III CREDIT-1 study...